Ligand validation:3BMO

D1D: (4S,5S)-1,2-DITHIANE-4,5-DIOL

D1D is a Ligand Of Interest in 3BMO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3BMO_D1D_B_273	81%	51%	0.112	0.965	0.9	0.98	-	-	7	0	100%	0.3
3BMO_D1D_C_274	64%	18%	0.145	0.944	1.46	2.04	1	2	2	0	100%	0.7
3BMO_D1D_A_276	62%	43%	0.146	0.937	1.4	0.84	1	-	3	0	100%	0.7
3BMO_D1D_D_273	42%	51%	0.183	0.903	1.03	0.87	1	-	2	0	100%	0.7
2X9N_D1D_B_1271	75%	37%	0.101	0.933	0.48	1.95	-	2	0	0	100%	0.9325
5P98_D1D_A_305	97%	14%	0.063	0.98	1.1	2.7	-	3	0	0	100%	0.5
2HEI_D1D_B_302	96%	22%	0.063	0.971	1.79	1.45	1	1	0	2	100%	1
3MNG_D1D_A_201	96%	9%	0.069	0.977	0.63	3.76	-	2	0	0	100%	1
5GI8_D1D_A_303	95%	47%	0.073	0.978	1.27	0.79	1	-	0	0	100%	1
5PA3_D1D_A_304	94%	29%	0.071	0.972	1.13	1.7	-	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.